February 1, 2021
Genprex Issues Shareholder Letter and Provides Corporate Update
Major milestones achieved in advancing gene therapies for lung cancer and diabetes Company looks toward launching key clinical trials in…
Pharmaceuticals, Biotechnology and Life Sciences
Major milestones achieved in advancing gene therapies for lung cancer and diabetes Company looks toward launching key clinical trials in…
DUBLIN–(BUSINESS WIRE)–The “Progressive Supranuclear Palsy Market Insight, Epidemiology and Market Forecast – 2030” drug pipelines has been added to ResearchAndMarkets.com’s…
Avacta’s next generation cell and gene therapy joint venture with Daewoong Pharmaceutical secures Series A venture funding CAMBRIDGE, England &…
BOSTON–(BUSINESS WIRE)–#ADPD—Invicro LLC, a Konica Minolta company announces that the paper, TauIQ – A canonical image-based algorithm to quantify tau…
BERLIN, Germany–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) a biotechnology company focused on improving cancer treatments by…
Enables 10x Faster Enrollment AUSTIN, Texas–(BUSINESS WIRE)–Elligo Health Research, a leading integrated research organization with relationships and access to over…
The application makes the power of AI accessible to pharma manufacturing while preserving GxP compliance, enabling data-driven decisions faster in…
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity…
DUBLIN–(BUSINESS WIRE)–The “Global Shrimp Disease Diagnostics Market (2020-2025) by Disease, Kit, End-User, Geography, Competitive Analysis and the Impact of Covid-19…
– Maralixibat U.S. launch expected in second half of 2021, if approved FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM)…